It has been a long and complicated story. The newspaper for the University of Copenhagen published "Penkowa for Dummies" in the spring of 2011, which gives a good background to the skirmishes of the past year.
Milena Penkowa, since resigned from her position as professor at the University of Copenhagen, had been the shooting star in research in Denmark. Sure, there had been some dark mutterings about her dissertation, as Nature reported in January 2011 on the basis of a report in Weekendavisen by Poul Pilgaard Johnsen. The thesis was first rejected, then accepted on a second review.
Then some of her research had to be retracted, as it was not replicable. Retraction Watch lists 2 papers out of over 100 that were retracted and two letters of concern that have been published in journals. And some research money had been used to pay for lawyers and restaurant visits. The university promised to start a full-fledged investigation.
The investigation was conducted by a group of foreign experts, Weekendavisen reports in its issue from July 20 (they are, unfortunately, not online). Hans Lassmann from the Medical University in Vienna chaired the committee that examined the 102 publications by Penkowa. 23 of the papers were deemed to be unnecessary to examine more closely. In 26 of the remaining 79 papers the committee determined scientific irregularities. Out of these 26 papers, 16 were determined to be scientific misconduct.
The misconduct has involved, among other things, mismatches between the number of lab animals in the papers and in the animal registers, problems with quantitative data, and problems with pictures (for example just turning the pictures as evidence of new work). The data archives were chaotic and filled with errors.
Berlingske, another Danish paper, reported July 15 by Claes Lautrup on the results of the investigation. Not only Penkowa, but also the University of Copenhagen were found to be guilty of misconduct. Penkowa still claims innocence, but notes that her career is ruined already, there is nothing left for her to give up. The university has refused to comment. By law, the report must be made public and is scheduled for August 7.
The university has started a new program for PhD students that includes mandatory courses in research ethics, good scientific practice, record keeping, and documentation, according to Weekendavisen.
The university must now decide what to do with the 16 articles, whether to contact the journals for retraction. They have already taken Penkowa to court on a case of defrauding university funds, which she blamed on a student. She lost the case and has been fined. She currently is running a company for advising patients with neurological problems and writing a book about dog psychology, Weekendavisen writes.
There is also a political aspect to the drama, involving the rector of the university and the former federal minister of science, but that is just an added layer of complication to an already tangled web.
(If there are any translation errors in my summary, please let me know! -dww)
Showing posts with label biomedical science. Show all posts
Showing posts with label biomedical science. Show all posts
Thursday, July 26, 2012
Saturday, May 9, 2009
Fake Journals
Now we not only have fake conferences and invented publications. If you have enough money (as pharmaceutical companies do), you can just purchase your own fancy-schmancy, scientific-sounding journal from a reputable publisher. Or shall we say, previously reputable. Now that six of their thousands of journals have been identified as fakes, maybe we should just assume that the rest are also problematic and proceed to take our papers to Open Access journals.
But let's start at the top. Many blogs (such as bioethics.net) and The Scientist reported that pharmaceutical company Merck was behind the "Australasian Journal of Bone and Joint Medicine". It looked like a real journal. It had real-looking articles in it, although they were reprints or summaries of other journal's research, all strangely enough favorable about Merck products. Summer Johnson on the bioethics blog points out the problem with this:
Laika's MedLibLog goes on to explain how some of the articles that were reprinted got themselves published in the first place: the company sponsors the research, and then employees of the company offer manuscripts to the academic investigators, who put their name on the paper (and sometimes forget the footnote explaining who paid for the research). So we have a "journal" with reprints of ghostwritten articles.
The Scientist has now found 6 similar journals:
Yes, the mother company regrets what its Australia division has been up to. And the people responsible apparently don't work there any more.
But how can we know for sure that the next Elsevier journal that we hold in our hands is legit? That it declares all of its interests and who paid for and wrote the research?
Can we now declare the peer-review system for journal articles officially broken? Can we also quit counting number of articles and impact factors and just have people submit the 3 of 5 most important papers they have written when they are evaluated?
Oh, the Elsevier statement is linked from their home page....
But let's start at the top. Many blogs (such as bioethics.net) and The Scientist reported that pharmaceutical company Merck was behind the "Australasian Journal of Bone and Joint Medicine". It looked like a real journal. It had real-looking articles in it, although they were reprints or summaries of other journal's research, all strangely enough favorable about Merck products. Summer Johnson on the bioethics blog points out the problem with this:
What’s wrong with this is so obvious it doesn’t have to be argued for. What’s sad is that I’m sure many a primary care physician was given literature from Merck that said, “As published in Australasian Journal of Bone and Joint Medicine, Fosamax outperforms all other medications….” Said doctor, or even the average researcher wouldn’t know that the journal is bogus. In fact, knowing that the journal is published by Elsevier gives it credibility!Right. Elsevier used to be a respected name in scientific publishing. The Guardian quotes a spokesman as saying that the publisher does not consider this a journal, as it is a compilation of reprinted articles. Then why does it have the word "Journal" in its title?
Laika's MedLibLog goes on to explain how some of the articles that were reprinted got themselves published in the first place: the company sponsors the research, and then employees of the company offer manuscripts to the academic investigators, who put their name on the paper (and sometimes forget the footnote explaining who paid for the research). So we have a "journal" with reprints of ghostwritten articles.
The Scientist has now found 6 similar journals:
- the Australasian Journal of General Practice
- the Australasian Journal of Neurology
- the Australasian Journal of Cardiology
- the Australasian Journal of Clinical Pharmacy
- the Australasian Journal of Cardiovascular Medicine, and
- the Australasian Journal of Bone & Joint Medicine.
Yes, the mother company regrets what its Australia division has been up to. And the people responsible apparently don't work there any more.
But how can we know for sure that the next Elsevier journal that we hold in our hands is legit? That it declares all of its interests and who paid for and wrote the research?
Can we now declare the peer-review system for journal articles officially broken? Can we also quit counting number of articles and impact factors and just have people submit the 3 of 5 most important papers they have written when they are evaluated?
Oh, the Elsevier statement is linked from their home page....
Subscribe to:
Posts (Atom)